Stability of full-length recombinant FVIII formulated with sucrose during continuous infusion using a mini-pump infusion device.
Henze
W
W
Kellermann
E
E
Larson
P
P
Gorina
E
E
D005169:Factor VIII / Q000008:administration & dosage / Q000737:chemistry* / Q000627:therapeutic use; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D007260:Infusion Pumps; D007262:Infusions, Intravenous; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000737:chemistry*; D015203:Reproducibility of Results; D013395:Sucrose / Q000737:chemistry*; D013997:Time Factors
D011994:Recombinant Proteins; D013395:Sucrose; C078147:F8 protein, human; D005169:Factor VIII